Marie-Claure Morice was present during the PCR Tokyo Valve as Course...
CERC Asia, our recently founded Singapore-based subsidiary, will be introduced at the Innovators day during AsiaPCR, which takes place on 18th January 2017. Come and discuss with us important topics in clinical research and new technologies in the cardiovascular therapeutic...
CERC will be present at AsiaPCR 2017 in Singapore, which will take place from 19th to 21st of January 2017. We are delighted to welcome you at booth...
We are proud to announce that the results of Leaders free and Oppose trials, sponsored respectively by Biosensors and Occlutech, and which were managed by CERC will be presented during this year’s TCT congress: LEADERS FREE : Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk. Presented by Dr Philip Urban on Sunday , Oct 30. 12:45 PM. Main Arena LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial . Presented by Pr Didier Carriée on Monday, Oct 31. 1:15 PM. Room 143A OPPOSE: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry. Presented by David Hildick-Smith on Monday , Oct 31. 12:45 PM. Room 144B Person to be contacted during the congress: Marie-Claude...
CERC and BePatient are happy to announce the lounge of UP SMART FOLLOW UP, a company dedicated to connected follow up of patients in clinical...
CERC is happy to announce that CERC Asia is now open. Clinical research has no frontiers and is rapidly expanding in Asia in parallel with the growing number of patients undergoing treatment. As CERC is involved in several ongoing trials conducted in Asian sites, we decided to set up CERC ASIA in Singapore in order to coordinate the trials directly from this strategic region and support Asian research whenever...
